The importance of ensuring that pharmacist-provided clinical services are represented in the electronic health record has come to the forefront with the Pharmacy e-Health Information Technology Collaborative.
The importance of ensuring that pharmacist-provided clinical services are represented in the electronic health record (EHR) has come to the forefront with the Pharmacy e-Health Information Technology Collaborative (Collaborative), an organization founded by 9 national pharmacy organizations.
Launched in September 2010, the Collaborative's goal is to help pharmacists receive bi-directional information and functionality with electronic prescribing and other aspects of the certified EHR in order to participate in multidisciplinary patient care. In addition, the Collaborative integrates the pharmacist's role of providing patient-care services into the US Health Information Technology (HIT) infrastructure.
The Collaborative was developed to assure the meaningful use of standardized EHRs, supporting safe, efficient, and effective medication use, continuity of care, and provision of access to patient-care services by pharmacists with other members of the interdisciplinary patient-care team.
"Pharmacists providing patient-care services need a standard EHR to document and electronically exchange health information with other healthcare providers," said the Collaborative's Director Rachelle "Shelly" Spiro, RPh.
According to Dr Spiro, for pharmacists to be meaningful users of the EHR, pharmacists worked with standard development organizations to develop the Pharmacist/Pharmacy Provider EHR (PP-EHR) functional profile. The PP-EHR or Pharmacist EHR was developed by a joint Health Level Seven (HL7) and National Council for Prescription Drug Programs (NCPDP) work group and it has been approved through the balloting process of both organizations.
The Collaborative also has associate members who represent e-prescribing networks, a standards development organization, and a transaction processing network.
The Collaborative represents more than 250,000 pharmacists in different aspects of pharmacy practice, including pharmacy education, clinical pharmacy, retail pharmacy, consulting, and others, as well as the National Alliance of State Pharmacy Associations, and the National Community Pharmacists Association. The Collaborative influences HIT policy through unified, regular communication exchanges to the Centers for Medicare and Medicaid Services (CMS), Office of the National Coordinator (ONC), and other HIT organizations about pharmacists' contributions and pharmacist-provided patient-care services to the ONC and CMS defined meaningful use of the EHR.
For more information, visit http://www.pharmacye-hit.org/.
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
July 1st 2020In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.
Listen
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
July 1st 2020In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.
Listen
2 Commerce Drive
Cranbury, NJ 08512